Tampons May Be a Source of Metal Exposure
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, July 11, 2024 -- Tampon use is a potential source of metal exposure, according to a study published in the August issue of Environmental International.
Jenni A. Shearston, Ph.D., from the School of Public Health at the University of California Berkeley, and colleagues compared the concentrations of 16 metal(loid)s (arsenic, barium, calcium, cadmium, cobalt, chromium, copper, iron, manganese, mercury, nickel, lead, selenium, strontium, vanadium, and zinc) in 30 tampons from 14 tampon brands and 18 product lines.
The researchers found measurable concentrations of all 16 assessed metals, including detectable concentrations of several toxic metals, with elevated mean concentrations of lead (geometric mean [GM], 120 ng/g), cadmium (GM, 6.74 ng/g), and arsenic (GM, 2.56 ng/g). There were differences seen in metal concentrations by region of tampon purchase (United States versus European Union/United Kingdom), by organic versus nonorganic material, and for store- versus name-brand tampons. For example, lead concentrations were higher in nonorganic tampons, while arsenic was higher in organic tampons. Consistently lower concentrations of metals were not seen for any single category.
"Future research is needed to replicate our findings and determine whether metals can leach out of tampons and cross the vaginal epithelium into systemic circulation," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-12 01:15
Read more
- Brief Cognitive Behavioral Therapy Via Telehealth Cuts Suicide Attempts
- Linerixibat Shows Positive Phase III Results in Cholestatic Pruritus in Primary Biliary Cholangitis (PBC)
- Bystanders More Readily Perform CPR If 911 Operator Instructs
- No Long-Term Cognitive Effects Seen for Menopausal Hormone Therapy
- Too Many Meds: 'Polypharmacy' Can Really Harm Alzheimer's Patients
- FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions